High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

<i>Background</i>: The evidence on high-dose ifosfamide (HD-IFO) use in patients with relapsed osteosarcoma is limited. We performed a retrospective study to analyze HD-IFO activity. <i>Methods</i>: Patients with osteosarcoma relapsed after standard treatment [methotrexate, d...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani, Lorenzo D’Ambrosio, Alessandro Comandone, Alberto Righi, Alessandra Longhi, Marilena Cesari, Anna Paioli, Rossella Hakim, Michela Pierini, Emanuela Marchesi, Daniel Vanel, Ymera Pignochino, Davide Maria Donati, Piero Picci, Stefano Ferrari
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2020-10-01
Cyfres:Cells
Pynciau:
osteosarcoma
high-grade bone sarcoma
pediatric bone tumors
ifosfamide
chemotherapy
PARP1
Mynediad Ar-lein:https://www.mdpi.com/2073-4409/9/11/2389
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg